A Study of the Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative Breast
Clinical trial NCT04481763 · RECRUITING
Trial details
- NCT number
- NCT04481763
- Sponsor
- Jiangxi Provincial Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-14
- Primary completion
- 2024-08-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.